Mirae Asset China leads $50m Series C round for aesthetics startup Puliyan

Mirae Asset China leads $50m Series C round for aesthetics startup Puliyan

Photo from Pixabay

31 July, 2025

Edited by: Joymitra Rai

Alwin Capital Huatai Zijin Investment medical aesthetics medical devices Mirae Asset Capital (China)NMPA Puliyan regenerative aesthetics

Printed by Unregistered user on Sun, 21 Dec 2025 15:32:13 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Chinese medical devices startup BrioHealth Solutions bags $100m

Chinese beauty brands explore foreign M&A to spur growth

Read more from Greater China

Policy & Regulations

China issues new rules to regulate internet platform pricing

Chinese humanoid robot developer Galbot raises $300m at $3b valuation